Health Insurance - Coverage for Specialty Drugs - Rheumatologic Conditions

Summary

The bill bars insurers, nonprofit health plans and HMOs from denying coverage for certain specialty drugs used to treat rheumatologic conditions when the drugs are administered or dispensed by an in‑network rheumatology provider that follows state regulations. It also requires reimbursement rates to be negotiated with those providers and limits the rates to non‑hospital levels, preventing higher payments to designated specialty pharmacies. The measure seeks to improve patient access and create fairer payment rules for office‑based drug dispensing.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share